Letter to the Editor: comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis

被引：0
|
作者：
Parekh, Krupa [1 ]
Watkins, Claire [2 ]
机构：
[1] F Hoffmann La Roche Ltd, Basel, Switzerland
[2] Clarostat Consulting Ltd, Macclesfield, Cheshire, England
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2021年 / 10卷 / 17期
关键词：
disease-modifying therapies; multiple sclerosis; network meta-analysis; relapsing multiple sclerosis;
D O I：
10.2217/cer-2021-0123
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1265 / 1266
页数：2
相关论文
共 50 条
  • [1] Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
    Samjoo, Imtiaz A.
    Worthington, Evelyn
    Drudge, Christopher
    Zhao, Melody
    Cameron, Chris
    Haering, Dieter A.
    Stoneman, Dee
    Klotz, Luisa
    Adlard, Nicholas
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (18) : 1255 - 1274
  • [2] Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis
    Rosa C. Lucchetta
    Fernanda S. Tonin
    Helena H. L. Borba
    Letícia P. Leonart
    Vinicius L. Ferreira
    Aline F. Bonetti
    Bruno S. Riveros
    Jefferson Becker
    Roberto Pontarolo
    Fernando Fernandez-Llimós
    Astrid Wiens
    CNS Drugs, 2018, 32 : 813 - 826
  • [3] Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis
    Lucchetta, Rosa C.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Leonart, Leticia P.
    Ferreira, Vinicius L.
    Bonetti, Aline F.
    Riveros, Bruno S.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    CNS DRUGS, 2018, 32 (09) : 813 - 826
  • [4] Relapse reduction by disease-modifying therapies for relapsing multiple sclerosis: A network meta-analysis
    Stoneman, D.
    Drudge, C.
    Zhao, M.
    Worthington, E.
    Cameron, C.
    Haring, D.
    Samjoo, I.
    Adlard, N.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 739 - 739
  • [5] Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis
    Lucchetta, Rosa C.
    Leonart, Leticia P.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 7 - 15
  • [6] COST-EFFECTIVENESS OF OFATUMUMAB COMPARED WITH OTHER DISEASE-MODIFYING THERAPIES FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS IN GREECE
    Petropoulos, A.
    Cooney, P.
    Patidar, M.
    Gudala, K.
    Tiwari, S.
    Brennan, R.
    Kapsogeorgiou, K.
    Cheilas, G.
    Banhazi, J.
    VALUE IN HEALTH, 2022, 25 (12) : S80 - S81
  • [7] Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis
    Chen, Chaoyang
    Zhang, Enyao
    Zhu, Chunsu
    Wei, Ran
    Ma, Lingyun
    Dong, Xiu
    Li, Ruoming
    Sun, Feng
    Zhou, Ying
    Cui, Yimin
    Liu, Zhenming
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (01) : 8 - +
  • [8] Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
    Fogarty, Emer
    Schmitz, Susanne
    Tubridy, Niall
    Walsh, Cathal
    Barry, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 23 - 30
  • [9] A Network Meta-Analysis of Randomized Controlled Trials to Evaluate the Comparative Efficacy of Disease-Modifying Therapies for Patients with Relapsing Multiple Sclerosis
    Drudge, C.
    Walsh, S.
    Tiwari, S.
    Brennan, R.
    Boer, I.
    Haring, D. A.
    Klotz, L.
    Adlard, N.
    Banhazi, J.
    Samjoo, I. A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 39 - 40
  • [10] Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
    Huihui Li
    Fengli Hu
    Yanli Zhang
    Kai Li
    Journal of Neurology, 2020, 267 : 3489 - 3498
12345